Institute for Protein Design

Seattle, WA, USA

The Institute for Protein Design develops novel proteins using artificial intelligence and computational methods for applications in medicine, therapeutics, sustainable chemistry, and environmental remediation. It aims to create custom-designed enzymes and protein structures to address challenges such as gene therapy delivery, biocatalysis, and plastic degradation.

Facts

HQ
Seattle, WA, USA
Sectors
Biotechnology, Protein design, Computational biology, AI/ML

Is this your organization? Claim it

Lila Bio wins $3.65M NIH SBIR grant to develop AI-designed long‑acting injectable for pulmonary hypertension

Lila Bio, spun out of David Baker’s UW lab, won a $3.65 million NIH SBIR grant to develop an AI-designed, long-acting injectable protein therapy aimed at modifying disease in pulmonary hypertension. The funding covers two phases—$605,981 for initial animal studies and $3,049,462 for further animal work and patient lung-tissue studies—and builds on Lila’s 2023 $10M seed raise and prior collaboration with Eli Lilly.

See all 75 news stories about Institute for Protein Design.